Novartis combo therapy for melanoma gets FDA priority review
The review covers combination therapy for the adjuvant treatment of patients with stage III melanoma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Trial results of Zika vaccine Sanofi dropped show promise
The ZPIV vaccine, made from inactivated Zika virus particles, was developed by US Army researchers, who in July 2016 had agreed to…
FDA approves Novo Nordisk diabetes drug Ozempic
The company said it plans to price the drug at $676 per prescription, which it described as ‘at parity’ to current market-leading…
FDA approves heart protection claims for Amgen cholesterol drug
A study released in March of more than 27,500 patients showed that Repatha cut the risk of heart attacks by 27 per cent and stroke…
Cancer drug prompts ‘drastic’ HIV decrease in lung cancer patient
Opdivo, or nivolumab is a PD-1 inhibitor, designed to help the body’s own immune system fend off cancer by blocking a protein…
FDA aims to approve more drugs based on early clinical data
Cancer drugs that cause tumours to shrink are considered likely to confer a meaningful clinical benefit, such as survival
Men more likely to develop serious heart condition, infective endocarditis, as women: Study
The new study allows prevention measures to be targeted at those individuals most at risk of developing IE
FDA OKs Mylan’s biosimilar of Roche cancer drug Herceptin
Herceptin and other complex medicines called biologics are made from living cells, making them difficult to copy with precision
Can Indian Pharma Inc find its lost mojo?
Ashish Prasad, Partner, Economic Laws Practice, Indian Pharma Inc will need to take stock of the current situation and chalk out a…
Policy experiences of 2017 for pharma sector
Krishna Sarma, Managing Partner of Corporate Law Group, gives an insight about the need to take positive learnings from the…